RNS Number : 7390D

Venture Life Group PLC

01 April 2014



For immediate release 1 April 2014

Venture Life Group plc

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii			Venture Life Group plc
2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights				√
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments
An event changing the breakdown of voting rights
Other (please specify):
3. Full name of person(s) subject to the notification obligation: iii		Aviva plc & its subsidiaries
4. Full name of shareholder(s)  (if different from 3.):iv		Registered Holder: BNY Norwich Union Nominees Limited       60,931* Chase (GA Group) Nominees Limited      1,725,751* * denotes direct interest   Chase (GA Group) Nominees Limited         276,095 Chase Nominees Limited                               69,817 Vidacos Nominees Limited                          289,424
5. Date of the transaction and date on which the threshold is crossed or reached: v		28 March 2014
6. Date on which issuer notified:		31 March 2014
7. Threshold(s) that is/are crossed or reached: vi, vii		0% to >7% Change at Direct Interest Level 0% to >5% Change at Combined Interest Level

8. Notified details:
A: Voting rights attached to shares viii, ix
Class/type of shares if possible using the ISIN CODE	Situation previous to the triggering transaction				Resulting situation after the triggering transaction
	Number of Shares		Number of Voting Rights		Number of shares	Number of voting rights			% of  voting rights x
					Direct	Direct xi		Indirect xii	Direct		Indirect
Ordinary Shares GB00BFPM8908	Below Threshold		Below Threshold		2,422,018	1,786,682		635,336	7.36%		2.62%
B: Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial instrument		Expiration date xiii		Exercise/ Conversion Period xiv			Number of voting rights that may be acquired if the instrument is exercised/ converted.			% of voting rights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi
Resulting situation after the triggering transaction
Type of financial instrument	Exercise price	Expiration date xvii	Exercise/ Conversion period xviii	Number of voting rights instrument refers to	% of voting rights xix, xx
					Nominal	Delta

Total (A+B+C)
Number of voting rights	Percentage of voting rights
2,422,018	9.98%

9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable: ^xxi

The voting rights are managed and controlled by Aviva Investors Global Services Limited, with the following chain of controlled undertakings:-

Aviva Investors Global Services Limited:

·    Aviva plc (Parent Company)

·    Aviva Group Holdings Limited (wholly owned subsidiary of Aviva plc)

·    Aviva Investors Holdings Limited (wholly owned subsidiary of Aviva Group Holdings Limited)

·    Aviva Investors Global Services Limited (wholly owned subsidiary of Aviva Investors Holdings Limited)

Proxy Voting:
10. Name of the proxy holder:		See Section 4
11. Number of voting rights proxy holder will cease to hold:
12. Date on which proxy holder will cease to hold voting rights:
13. Additional information:	Figures are based on a total number of voting rights of  24,264,141 as per the Company's 'Admission to AIM and acquisition of Biokosmes Srl' Announcement of 28 March 2014.
14. Contact name:	Neil Whittaker, Aviva plc
15. Contact telephone number:	01603 684420

This information is provided by RNS

The company news service from the London Stock Exchange

END HOLEAALFEESLEFF